Trending...
- New Slotozilla Project Explores What Happens When the World Goes Silent
- "Leading From Day One: The Essential Guide for New Supervisors" Draws from 25+ Years of International Management Experience
- CCHR, a Mental Health Watchdog Organization, Hosts Weekly Events Educating Citizens on Important Mental Health Issues
Download
Multi Radiance Medical has become the first laser therapy manufacturer to receive FDA clearance to treat pain associated with fibromyalgia. (Photo: Business Wire)
SOLON, Ohio--(BUSINESS WIRE)--Multi Radiance Medical (MRM) has become the first laser therapy manufacturer to receive FDA clearance to treat pain associated with fibromyalgia.
More on Ohio Pen
The American College of Rheumatology defines fibromyalgia as chronic widespread pain and tenderness in specific tender points characterized by muscular tenderness, pain, fatigue, and cognitive difficulties. With no known cause or cure, fibromyalgia is usually treated with prescription medications; however, they only provide relief for approximately 10% of patients who use them.
Through a photoceutical approach to care, the new patent-pending MRM FibroLux therapy laser represents a breakthrough in pain management options, offering patients a non-pharmacological, non-invasive, and side effect-free treatment for fibromyalgia that is now cleared by the FDA. Like pharmaceuticals, photoceutical devices are validated through clinical studies and deliver optimal doses of light energy using a combination of curated wavelengths, administered at the correct dose (time and power), and the ideal dosage (frequency of application) resulting in consistent, reproducible outcomes.
In a clinical trial, MRM's FibroLux laser was found to reduce tender point count, mean pain ratings, and Fibromyalgia Impact Questionnaire (FIQ) scores compared to placebo. Overall findings demonstrated that the FibroLux delivers a safe and effective treatment for reducing fibromyalgia pain, and treatment times last an average of 3-6 minutes.
For more than 15 years, MRM has validated the efficacy of its therapeutic lasers through published research. Over the past decade and a half, 59+ peer-reviewed articles have been published about MRM's technology and MRM has participated in over 35 clinical trials globally.
"Laser therapy has been a game-changer in the rehabilitation and pain management space for years. Now, as the first laser company to achieve a patent and FDA clearance for relief of fibromyalgia pain, this opens the door for how to effectively manage this tough condition," says MRM CEO Max Kanarsky. "We want to thank our research team for their efforts in the clinical trial process as we continue to expand the applications of laser therapy."
More on Ohio Pen
To read more about the science behind treating fibromyalgia with laser therapy, download A Photoceutical Approach to Treating Fibromyalgia: A Scientific Monograph.
About Multi Radiance Medical
Multi Radiance Medical is a leading medical device company that develops and manufactures FDA-cleared laser therapy equipment for the temporary relief of acute/chronic pain, muscle stiffness, arthritis, muscle spasms, chronic neck and shoulder pain of musculoskeletal origin, pain associated with fibromyalgia, and other conditions. Multi Radiance Medical has served rehabilitation, chiropractic, physiatry, sports medicine and veterinary markets for 20 years and the technology is utilized in more than 30 countries.
Contacts
Media Contact
Douglas Johnson, Senior Vice President of Clinical and Scientific Affairs
djohnson@multiradiance.com
734-624-5280
Release Summary
Multi Radiance Medical has become the first laser therapy manufacturer to receive FDA clearance to treat pain associated with fibromyalgia.
0) { // Create container for hi-res image jQuery('#bw-release-hires').append('
'); }; }); ]]>
Social Media Profiles
Contacts
Media Contact
Douglas Johnson, Senior Vice President of Clinical and Scientific Affairs
djohnson@multiradiance.com
734-624-5280
Multi Radiance Medical has become the first laser therapy manufacturer to receive FDA clearance to treat pain associated with fibromyalgia. (Photo: Business Wire)
- Multi Radiance Medical has become the first laser therapy manufacturer to receive FDA clearance to treat pain associated with fibromyalgia. (Photo: Business Wire)
SOLON, Ohio--(BUSINESS WIRE)--Multi Radiance Medical (MRM) has become the first laser therapy manufacturer to receive FDA clearance to treat pain associated with fibromyalgia.
More on Ohio Pen
- $20 Price Target in Noble Capital Research Report as Deal is Signed for NFL Yearbook Advertising Across 25 Stadiums for AI Powered Sports Leader $SEGG
- 3E Launches First AI Agent Designed to Respond with Empathy for College Recruitment
- Security Alert: TZNXG Warns Investors About "Fund Recovery" Scams
- Assent Unveils Extended Producer Responsibility Packaging Solution to Simplify Compliance with Expanding Packaging Laws
- KatalisCoin: "Too Secure" for Bad Actors - Platform Embraces "Excessive Compliance" Criticism
The American College of Rheumatology defines fibromyalgia as chronic widespread pain and tenderness in specific tender points characterized by muscular tenderness, pain, fatigue, and cognitive difficulties. With no known cause or cure, fibromyalgia is usually treated with prescription medications; however, they only provide relief for approximately 10% of patients who use them.
Through a photoceutical approach to care, the new patent-pending MRM FibroLux therapy laser represents a breakthrough in pain management options, offering patients a non-pharmacological, non-invasive, and side effect-free treatment for fibromyalgia that is now cleared by the FDA. Like pharmaceuticals, photoceutical devices are validated through clinical studies and deliver optimal doses of light energy using a combination of curated wavelengths, administered at the correct dose (time and power), and the ideal dosage (frequency of application) resulting in consistent, reproducible outcomes.
In a clinical trial, MRM's FibroLux laser was found to reduce tender point count, mean pain ratings, and Fibromyalgia Impact Questionnaire (FIQ) scores compared to placebo. Overall findings demonstrated that the FibroLux delivers a safe and effective treatment for reducing fibromyalgia pain, and treatment times last an average of 3-6 minutes.
For more than 15 years, MRM has validated the efficacy of its therapeutic lasers through published research. Over the past decade and a half, 59+ peer-reviewed articles have been published about MRM's technology and MRM has participated in over 35 clinical trials globally.
"Laser therapy has been a game-changer in the rehabilitation and pain management space for years. Now, as the first laser company to achieve a patent and FDA clearance for relief of fibromyalgia pain, this opens the door for how to effectively manage this tough condition," says MRM CEO Max Kanarsky. "We want to thank our research team for their efforts in the clinical trial process as we continue to expand the applications of laser therapy."
More on Ohio Pen
- Keyanb Exchange Implements Enhanced Security Protocols Amid Industry-Wide Trust Challenges
- TSWHZC Platform Combines Automated Portfolio Management with Proof of Reserves for Brazil Market Entry
- AureaVault Positions Digital Asset Infrastructure for Shifting Monetary Policy Environment
- JQRBT Unveils High-Speed Trading Infrastructure Designed for Growing Institutional Crypto Market
- Hammes celebrates the opening of the Franklin County Crisis Care Center in Columbus, Ohio
To read more about the science behind treating fibromyalgia with laser therapy, download A Photoceutical Approach to Treating Fibromyalgia: A Scientific Monograph.
About Multi Radiance Medical
Multi Radiance Medical is a leading medical device company that develops and manufactures FDA-cleared laser therapy equipment for the temporary relief of acute/chronic pain, muscle stiffness, arthritis, muscle spasms, chronic neck and shoulder pain of musculoskeletal origin, pain associated with fibromyalgia, and other conditions. Multi Radiance Medical has served rehabilitation, chiropractic, physiatry, sports medicine and veterinary markets for 20 years and the technology is utilized in more than 30 countries.
Contacts
Media Contact
Douglas Johnson, Senior Vice President of Clinical and Scientific Affairs
djohnson@multiradiance.com
734-624-5280
Release Summary
Multi Radiance Medical has become the first laser therapy manufacturer to receive FDA clearance to treat pain associated with fibromyalgia.
0) { // Create container for hi-res image jQuery('#bw-release-hires').append('
'); }; }); ]]>
Social Media Profiles
- Multi Radiance Medical on Facebook
- Multi Radiance Medical on LinkedIn
- Multi Radiance Medical on YouTube
- Multi Radiance Medical on Instagram (https://www.instagram.com/multiradiance/)
Contacts
Media Contact
Douglas Johnson, Senior Vice President of Clinical and Scientific Affairs
djohnson@multiradiance.com
734-624-5280
Filed Under: Business
0 Comments
Latest on Ohio Pen
- Broadway Gala Honored Also an Italian
- Bullen Ultrasonics' Eric Norton to Speak at MS&T Conference on Advanced Machining of Hard and Brittle Materials
- $ONI Listed on MEXC as ONINO Powers Europe's Tokenization Engine Into Public Platform Launch
- AZETHIO Crypto Exchange Whitepaper Reveals MPC-Secured Infrastructure Processing 1.2 Million Transactions Per Second
- CELOXFI Platform Demonstrates Advanced Security Architecture and Regulatory Framework
- Work 365 Launches PV 3.0: The Keystone Power App for Microsoft CSPs
- Local consultant shows small businesses how to turn red tape into real money
- Retirement Expert Mark E. Caner Joins Tom Hegna on the Podcast "Financial Freedom with Tom Hegna"
- Tour Napa Like a Local: Vines of Napa Valley Wine Passport AKA Vine Pass Unlocks Hidden Gems
- Dental Surgical Center Accepts Sedation Patients with Medicaid for MD, WV, PA and DC
- Sloan's Lake Dental Launches New Website to Enhance Patient Experience and Access to Modern Dental Care
- Only 3 Weeks Left till the Start of the OpenSSL Conference 2025
- ENTOUCH Completes $50 million Funding Round
- Meridian Bioscience Eliminates Cold Chain with the First Liquid Ambient Temperature Stable qPCR Master Mixes
- Teaming Agreement with Emtel Energy USA to Advance Thin-Film PV Energy Storage Capabilities; NASA agreements for Solar Space Tech; Ascent Solar $ASTI
- Nebuvex Acknowledges Platform "Too Secure" for Anonymous Traders; Institutional Investors Disagree
- From Tokyo to Berlin: FreeTo.Chat Unites Cultures with the World's First Confession VRX — EmojiStream™
- AZETHIO Launches Multi-Million Dollar User Protection Initiative Following Unprecedented Platform Growth
- Matecrypt Observes South American Cryptocurrency Adoption Surge Amid Economic Shifts
- Assent Uncovers Over 695 Unique PFAS Across Global Supply Chains as Regulations Increase